Pharmafile Logo

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand

The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to use it for virtually launching a brand!

Over the last year, we’ve learned that pretty much anything you can do in person can also be done virtually. In fact, we now know many things can actually be done more effectively using a virtual or hybrid approach. Additionally, a growing number of stakeholders are becoming “digital natives” who prefer the virtual/hybrid format to in-person meetings. The virtual/hybrid format allows for more frequent touchpoints, including with hard-to-reach healthcare providers (HCPs) and patients. Further, it results in higher qualities and quantities of insights collected.

The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. In this article, we share 10 of the most popular ways to use it for virtually launching a brand, including:

1. Review and coordination of clinical studies

2. Regulatory discussions and planning

3. Market access discussions

4. Treatment pathway profiling

5. Patient journey mapping and PSP development

6. Virtual and hybrid medical education programs (pre-launch)

7. Internal team collaboration

8. Field force training and product rollouts

9. Virtual and hybrid medical education programs (post-launch)

10. Ongoing patient, physician, nurse, and allied healthcare provider advisory boards

Access the full article here to learn more!

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

There’s No Going Back: How COVID-19 will Change Pharma Forever

Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches...

Powering Rapid Cognitive Analysis with AI

Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.

KOL Ambassador Program & Podcast Creation: A Customer Story

Leveraging Impetus Digital’s best-in-class synchronous (real-time) and asynchronous (over-time, anytime) tools, our client facilitated a virtual ambassador program with three oncologist key opinion leaders (KOLs) from South Korea.The client’s main objectives...

Importance of Emotional Intelligence in Pharma and Medical Affairs

Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, explores a number of interesting topics related to Medical Affairs. Among many other things, she discusses the importance of emotional...

Virtual product launch planning: the ultimate playbook

We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...

Navigating the Nuances of Europe’s MedTech Industry

Richard Houlihan, CEO of EirMed, explores topics related to EUDAMED, the European Databank for Medical Devices, including the key pain points and concerns MedTech companies encounter related to EUDAMED and...

Pharma, Technology, and Healthcare in the New Normal

Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma conducts clinical trials and interacts with...